Continued coverage of research led by Jamie Lo, M.D., M.C.R., and published in JAMA Pediatrics that found consuming cannabis while pregnant appears to increase the odds of preterm birth, low birth weight and infant death; Lo says: “The most striking finding is the increased risk of perinatal mortality — death either during the pregnancy or shortly after the pregnancy.”

Continued coverage of research led by Jamie Lo, M.D., M.C.R., and published in JAMA Pediatrics that found consuming cannabis while pregnant appears to increase the odds of preterm birth, low birth weight and infant death; Lo says: “The most striking finding is the increased risk of perinatal mortality — death either during the pregnancy or shortly after the pregnancy.”

The proposed merger of Legacy Health and Oregon Health & Science University will not move forward.

OHSU, Legacy Health agree to terminate plans to integrate organizations.

Brain & Life magazine interviews David Spencer, M.D., regarding new guidelines about when people with epilepsy can obtain a driver’s license and resume driving: “A uniform approach across the country is recommended, rather than the current patchwork of rules based on what state you live in.”

OHSU and the University of Michigan receive $2.8 million from the Juvenile Diabetes Foundation to expand the existing Breakthrough T1D Center of Excellence at the University of Michigan and establish an innovative clinical trial that tests promising heart and kidney therapies in people with type 1 diabetes.

JAMA Network News & Analysis publishes an article about why and how the FDA wants to end the use of synthetic food dyes. Joel Nigg, Ph.D., says the data show “that the food dyes are a community exposure hazard analogous to something like air pollution, with some individuals more vulnerable than others,” noting “the effect is small — dyes contribute a bit to ADHD but are not a major cause.”

An OHSU study presented at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Disease finds changes in sex hormone levels are associated with increased risk for sarcopenia – a gradual loss of muscle mass, strength and function -- among men.

OHSU is among the top 25 CRNA schools in 2025, according to U.S. News & World Report’s "Best Grad School" rankings.